Source: International Congress 2015 – IPF: clinical aspects
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Rita Daniela Gomes Matos (Albergaria-a-Velha, Portugal), Rita Matos Gomes, Eva Padrão, Hans Dabó, Luísa Nascimento, Artur Vale, Inês Neves, Patrícia Mota, Natália Melo, António Morais. Idiopathic pulmonary fibrosis: Relationship between patient survival and distance-saturation product. Eur Respir J 2015; 46: Suppl. 59, 2042

Member's Comments

No comment yet.

Related content which might interest you: Idiopathic pulmonary fibrosis Source: School Course 2014 - Interstitial lung diseases Year: 2014 Idiopathic pulmonary fibrosis Source: International Congress 2018 – State of the art session: Interstitial lung diseases Year: 2018 Idiopathic pulmonary fibrosis Source: Eur Respir Monogr 2013; 62: 37-53 Year: 2013 Idiopathic pulmonary fibrosis Source: Eur Respir Monogr 2015; 68: 50-63 Year: 2015 Idiopathic pulmonary fibrosis (IPF): the patient journey Source: Virtual Congress 2020 – Clinical aspects of idiopathic pulmonary fibrosis Year: 2020 Validation of GAP score in Danish patients diagnosed with idiopathic pulmonary fibrosis Source: Annual Congress 2013 –Diffuse parenchymal lung disease II Year: 2013 Idiopathic pulmonary upper lobe fibrosis shows distinct features and poor prognosis compared to idiopathic pulmonary fibrosis Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis and rarities Year: 2013 Assessment of nutritional status in patients with idiopathic pulmonary fibrosis Source: International Congress 2016 – Long-term oxygen therapy, noninvasive ventilation, and other clinical variables in chronic lung diseases Year: 2016 Pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis: Comparison with COPD Source: Annual Congress 2013 –Exercise, physiotherapy techniques and assessment in different chronic conditions Year: 2013 Negative outcome of prednisone in possible idiopathic pulmonary fibrosis Source: International Congress 2016 – IPF clinical Year: 2016 Clinical features of patients with idiopathic pulmonary upper lobe-dominant fibrosis Source: International Congress 2016 – Orphan diseases I Year: 2016 Pirfenidone treatment in idiopathic pulmonary fibrosis: An Italian case series Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view Year: 2013 The six minute walking test: Clinical predictors of survival in idiopathic pulmonary fibrosis Source: Annual Congress 2013 –The latest insights in exercise testing and physical inactivity Year: 2013 Clinical characteristics and survival in patients with idiopathic pulmonary fibrosis with and without associated emphysema Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view Year: 2013 Role of midkine in idiopathic pulmonary fibrosis Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view Year: 2013 Idiopathic pulmonary fibrosis: Gender differences in survival and functional decline. A retrospective study Source: International Congress 2016 – IPF: from pathogenesis to treatment I Year: 2016 Idiopathic pulmonary fibrosis (IPF) Source: ERS Course 2016 Year: 2016 Plasma protein signature of idiopathic pulmonary fibrosis (IPF) Source: Annual Congress 2013 –Translational research to bridge the need within clinical decision making Year: 2013 Efficacy of pirfenidone in idiopathic pulmonary fibrosis: A single center experience Source: International Congress 2016 – IPF: from pathogenesis to treatment II Year: 2016 Pulmonary hypertension in idiopathic pulmonary fibrosis: Utility of HRCT Source: International Congress 2014 – COPD and PAH related imaging Year: 2014